Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Sarama Announces Change of Auditor February 17, 2026 Surface Metals Inc Engages Danayi Capital Corp. to Provide Digital Marketing Services February 17, 2026 How Rick Rule Reinvested His Silver Gains: 5 Silver Stocks He Owns February 17, 2026
Surface Metals Inc Engages Danayi Capital Corp. to Provide Digital Marketing Services February 17, 2026